Rheumatrex
PubChem Notes:
Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
Molecular Formula:
C20H22N8O5
InChI: InChI=1/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m1/s1/f/h25,29,32H,21-22H2
InChIKey: InChIKey=FBOZXECLQNJBKD-UCCLXRCLDF
SMILES: CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
Names:
Amethopterin L-
Antifolan
A-Methopterin
A-Methpterin
Hdmtx
Ledertrexate
Metatrexan
methotrexate
Mexate
Rheumatrex
(2R)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid
Registries:
PubChem CID 72440
PubChem ID 148896
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|